|Summary||A triple monoamine reuptake inhibitor developed by Hoffman-LaRoche in the 1970s as an antidepressant but discontinued, probably due to high abuse potential. Has not become popular as a recreational drug at this time. Acts as an SNDRI, mostly inhibits dopamine and noradrenaline.|
|Dose||Threshold: 12-15mg Low: 30-40mg Common: 40-60mg Heavy: 60-80mg |
NOTE: These doses are tentative and may need further research.